BioMarin Announces Governance Enhancements and Value Creation Initiatives

BioMarin Pharmaceutical Inc. , a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives to enhance corporate governance and long-term shareholder...

Related Keywords

California ,United States ,Boston ,Massachusetts ,Indiana ,Northeastern University ,Indiana University ,American ,Marni Kottle ,Daiichi Sankyo ,Iovance Biotherapeutics ,Richarda Meier ,Eli Lilly ,Traci Mccarty ,Mark Enyedy ,Marc Steinberg ,Athena Countouriotis ,Los Angeles ,Alexander Hardy ,Barbara Bodem ,Pediatric Hematology Oncology Program ,Head Of Corporate Development ,Exchange Commission ,Biomarin Pharmaceutical Inc ,University Of California ,Invacare Corporation ,Jones Day ,Pfizer ,Biotechnology Innovation Organization ,Prnewswire Biomarin Pharmaceutical Inc ,Committee Of The Board ,Bristol Myers Squibb ,Nasdaq ,Harvard Law School ,Enovis Corporation ,Company Establishes Strategic ,Fred Hutchinson Cancer Research Center ,Genzyme Corporation ,Financial Analyst For Irwin Management Company ,Dentsply Sirona Inc ,Mallinckrodt Pharmaceuticals ,Jp Morgan Securities ,American Cancer Society Of Eastern New England ,Tufts University School Of Medicine ,Syneos Health ,Goldman Sachs ,Marin Announces Governance Enhancements ,Value Creation ,Approves Appointment ,Three New Independent ,Establishes Strategic ,Operating Review Committee ,Marin Enters ,Information Sharing Agreements ,Marin Pharmaceutical ,Operating Review ,Biomarin Board ,Elliott Investment Management ,Cooperation Agreement ,Senior Portfolio Manager Marc Steinberg ,Nature Conservancy ,Interim Chief Financial Officer ,Senior Vice President ,Chief Financial Officer ,Chief Financial ,Vice President ,Financial Analyst ,Tirwin Management ,Turning Point Therapeutics ,Chief Executive Officer ,Chief Medical Officer ,Adverum Biotechnologies ,Ambit Biosciences ,Tufts University School ,Executive Vice President ,Corporate Development ,Proteostasis Therapeutics ,American Cancer Society ,Eastern New England ,Biotechnology Innovation ,Logicbio Therapeutics ,Akebia Therapeutics ,Fate Therapeutics ,Biomarin Pharmaceutical ,Quarterly Report ,